Cyrcadia

Cyrcadia, originally known as First Warning Systems, was founded with the mission to revolutionize breast cancer detection through innovative medical technology. The company's core vision is to provide women with early identification tools for breast wellness, thereby improving treatment options and outcomes. Cyrcadia offers the Cyrcadia Breast Monitor, a wearable device consisting of intelligent breast patches that track circadian temperature changes within breast tissue over a period of 6 to 24 hours. This data is then analyzed via a PC or mobile device to assess breast health, targeting the healthcare and primary care markets.

Notable individuals affiliated with Cyrcadia include experts in medical technology and healthcare innovation, though specific names are not provided. The company has garnered attention from investors focused on advancing medical diagnostics. Key achievements include the development and market introduction of their wearable breast monitor, which represents a significant advancement in non-invasive breast cancer screening. Cyrcadia's impact lies in its potential to provide earlier and more accurate detection of breast abnormalities, ultimately aiming to improve patient outcomes and reduce mortality rates associated with breast cancer.